Does the microbiota play a role in the pathogenesis of autoimmune diseases?

Gut

Volumn 64, Issue 2, 2015, Pages 332-341

  McLean, Mairi H ^a   Dieguez, Dario ^b   Miller, Lindsey M ^b   Young, Howard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Society for Women's Health Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DYSBIOSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PATIENT RISK; PREVALENCE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA;

EID: 84920971304     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308514     Document Type: Article

References (159)

1. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project: exploring the microbial part of ourselves in a changing world. Nature 2007;449:804-10.
2. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-19.
3. Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 2014;146:1449-58.
4. Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol Published Online First: 21 Jul 2014. doi:10.1016/ S2213-8587(14)70134-2
5. Shapiro H, Thaiss CA, Levy M, et al. The cross talk between microbiota and the immune system: metabolites take center stage. Curr Opin Immunol 2014;30:54-62.
6. Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012;489:220-30.
7. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-8.
8. Zeissig S, Blumberg RS. Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat Immunol 2014;15:307-10.
9. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
10. Joscelyn J, Kasper LH. Digesting the emerging role for the gut microbiome in central nervous system demyelination. Mult Scler 20:1553-9.
11. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013;13:800-12.
12. Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology 2014;146:1534-46.
13. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis 2014;35:249-55.
14. Roderburg C, Luedde T. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma. Gut Microbes 2014;5:441-5.
15. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014;146:1513-24.
16. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014;146:1489-99.
17. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet 2009;373:1999-2000.
18. Vehik K, Ajami NJ, Hadley D, et al. The changing landscape of type 1 diabetes: recent developments and future frontiers. Curr Diab Rep 2013;13:642-50.
19. Hakonarson H, Grant SF. GWAS and its impact on elucidating the etiology of diabetes. Diabetes Metab Res Rev 2011;27:685-96.
20. Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem 2011;57:176-85.
21. Bakay M, Pandey R, Hakonarson H. Genes involved in type 1 diabetes. Genes (Basel) 2013;4:499-521.
22. Alper CA, Husain Z, Larsen CE, et al. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 2006;27:89-95.
23. Oilinki T, Otonkoski T, Ilonen J, et al. Prevalence and characteristics of diabetes among Somali children and adolescents living in Helsinki, Finland. Pediatr Diabetes 2012;13:176-80.
24. Nielsen DS, Krych L, Buschard K, et al . Beyond genetics. Influence of dietary factors on gut microbiota on type 1 diabetes. FEBS Lett 2014;588:4234-43.
25. Kondrashova A, Hyöty H. Role of viruses and other microbes in the pathogenesis of type 1 diabetes. Int Rev Immunol 2014;33:284-95.
26. Boerner BP, Sarvetnick NE. Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann N Y Acad Sci 2011;1243:103-18.
27. Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 2012;55:2868-77.
28. Hara N, Alkanani AK, Ir D, et al. The role of the intestinal microbiota in type 1 diabetes. Clin Immunol 2013;146:112-19.
29. Zipris D. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2013;20:265-70.
30. Dunne JL, Triplett EW, Geyers D, et al. The intestinal microbiome in type 1 diabetes. Clin Exp Immunol 2014;177:30-7.
31. Brehm MA, Powers AC, Shultz LD, et al. Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harb Perspect Med 2012;2:a007757.
32. Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008;455:1109-13.
33. Hansen CH, Krych L, Nielsen DS, et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 2012;55:2285-94.
34. Alkanani AK, Hara N, Lien E, et al. Induction of diabetes in the RIP-B7.1 mouse model is critically dependent on TLR3 and MyD88 pathways and is associated with alterations in the intestinal microbiome. Diabetes 2014;63:619-31.
35. Tormo-Badia N, Hakansson, A, Vasudevan K, et al. Antibiotic treatment of pregnant non-obese diabetic (NOD) mice leads to altered gut microbiota and intestinal immunological changes in the offspring. Scand J Immunol 2014;80:250-60.
36. Sofi MH, Gudi R, Karumuthil-Melethil S, et al. pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence. Diabetes 2014;63:632-44.
37. Wolf KJ, Daft JG, Tanner SM, et al. Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. J Histochem Cytochem 2014;62:237-50.
38. Kriegel MA, Sefik E, Hill JA, et al. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci USA 2011;108:11548-53.
39. Markle JG, Frank DN, Adeli K, et al. Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes 2014;5:485-93.
40. Peng J, Narasimhan S, Marchesi JR, et al. Long term effect of gut microbiota transfer on diabetes development. Journal of Autoimmunity 2014;53:85-94.
41. King C, Sarvetnick N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS ONE 2011;6:e17049.
42. Zipris D. Toll-like receptors and type 1 diabetes. Adv Exp Med Biol 2010;654:585-610.
43. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006;49:2105-8.
44. Schwartz RF, Neu J, Schatz D, et al. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105 -2108. Diabetologia 2007;50:220-1.
45. Vaarala O. Human intestinal microbiota and type 1 diabetes. Curr Diab Rep 2013;13:601-7.
46. de Goffau MC, Fuentes S, van den Bogert B, et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 2014;57:1569-77.
47. Brown CT, Davis-Richardson AG, Giongo A, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 2011;610:e25792.
48. Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011;5:82-91.
49. Murri M, Leiva I, Gomez-Zumaquero JM, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med 2013;11:46.
50. Endesfelder D, zu Castell W, Ardissone A, et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 2014;63:2006-14.
51. Mejía-León ME, Petrosino JF, Ajami NJ, et al. Fecal microbiota imbalance in Mexican children with type 1 diabetes . Sci Rep 2014;4:3814.
52. Cardwell CR, Stene LC, Joner G, et al. Caesarean section is associated with an increased risk of childhood onset type 1 diabetes: a meta-analysis of observational studies. Diabetologia 2008;51:726-35.
53. Phillips J, Gill N, Sikdar K, et al. History of cesarean section associated with childhood onset of T1DM in Newfoundland and Labrador, Canada. J Environ Public Health 2012;2012:635097.
54. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010;107:11971-5.
55. Wallberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol 2013;34:583-91.
56. Lau K, Benitez P, Ardissone A, et al . Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 2011;186:3538-46.
57. Bedoya SK, Lam B, Lau K, et al. Th17 cells in immunity and autoimmunity. Clin Dev Immunol 2013;2013:986789.
58. Bosi E, Molteni L, Radaelli MG, et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006;49:2824-7.
59. Secondulfo M, Iafusco D, Carratù R, et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type 1 diabetic patients. Dig Liver Dis 2004;36:35-45.
60. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008;24:701-6.
61. Visser J, Rozing J, Sapone A, et al. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 2009;1165:195-205.
62. Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am 2012;22:639-60.
63. Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr 2014;168:272-8.
64. Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: an immunological jigsaw. Immunity 2012;36:907-19.
65. Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev 2014;260:221-34.
66. Mooney PD, Hadjivassiliou M, Sanders DS. Coeliac disease. BMJ 2014;348:g156.
67. Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50:624-8.
68. Nisticò L, Fagnani C, Coto I, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 2006;55:803-8.
69. Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010;42:295-302.
70. Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43:1193-201.
71. Wijmenga C, Gutierrez-Achury J. Celiac disease genetics: past, present and future challenges. J Pediatr Gastroenterol Nutr 2014;59(Suppl 1):S4-7.
72. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007;26:1217-25.
73. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88-93.
74. de Sousa Moraes LF, Grzeskowiak LM, de Sales Teixeira TF, et al. Intestinal microbiota and probiotics in celiac disease. Clin Microbiol Rev 2014;27:482-9.
75. Ou G, Hedberg M, Hörstedt P, et al. Proximal small intestinal microbiota and identification of rod-shaped bacteria associated with childhood celiac disease. Am J Gastroenterol 2009;104:3058-67.
76. Nistal E, Caminero A, Herran AR, et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm Bowel Dis 2012;18:649-56.
77. Cheng J, Kalliomäki M, Heilig HG, et al. Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol 2013;13:113.
78. de Meij TG, Budding AE, Grasman ME, et al. Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease. Scand J Gastroenterol 2013;48:530-6.
79. Collado MC, Calabuig M, Sanz Y. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol 2007;8:9-14.
80. Nadal I, Donat E, Ribes-Koninckx C, et al. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007;56:1669-74.
81. Sanz Y, Sanchez E, Marzotto M, et al. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol Med Microbiol 2007;51:562-8.
82. Collado MC, Donat E, Ribes-Koninckx C, et al. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009;62:264-9.
83. Schippa S, Iebba V, Barbato M, et al. A distinctive 'microbial signature' in celiac pediatric patients . BMC Microbiol 2010;10:175.
84. Di Cagno R, De Angelis M, De Pasquale I, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol 2011;11:219.
85. Sanchez E, Laparra JM, Sanz Y. Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol 2012;78:6507-15.
86. De Palma G, Kamanova J, Cinova J, et al. Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease. J Leukoc Biol 2012;92:1043-54.
87. Stoven S, Murray JA, Marietta EV. Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov 2013;8:445-57.
88. Laparra JM, Olivares M, Gallina O, et al. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS ONE 2012;7:e30744.
89. Olivares M, Laparra M, Sanz Y. Oral administration of Bifidobacterium longum CECT 7347 modulates jejuna proteome in an in vivo gliadin induced enteropathy animal model. J Proteomics 2012;77:310-20.
90. Freitag TL, Rietdijk S, Junker Y, et al. Gliadin-primed CD4 +CD45RBlowCD25-T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut 2009;58:1597-605.
91. Olivares M, Neef A, Castillejo G, et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut Published Online First: 17 Jun 2014. doi:10.1136/ gutjnl-2014-306931.
92. Sellitto M, Bai G, Serena G, et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS ONE 2012;7:e33387.
93. Wacklin P, Kaukinen K, Tuovinen E, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 2013;19:934-41.
94. Fernandez-Feo M, Wei G, Blumenkranz G, et al. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect 2013;19:E386-94.
95. Lähdeaho ML, Kaukinen K, Laurila K, et al. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology 2014;146:1649-58.
96. Francavilla R, Ercolini D, Piccolo M, et al. Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol 2014;80:3416-25.
97. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
98. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011;7:569-78.
99. Luckey D, Gomez A, Murray J, et al. Bugs & us: the role of the gut in autoimmunity. Indian J Med Res 2013;138:732-43.
100. Nielen MM, van Schaardenburg D, Reesink HW, et al. Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 2004;50:2423-7.
101. Kochi Y, Suzuki A, Yamamoto K. Genetic basis of rheumatoid arthritis: A current review. Biochem Biophys Res Commun 2014;452:254-62.
102. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-7.
103. Bogdanos DP, Smyk DS, Rigopoulou EI, et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012;38:J156-69.
104. Paget SA. The microbiome, autoimmunity, and arthritis: cause and effect: an historical perspective. Trans Am Clin Climatol Assoc 2012;123:257-66.
105. Sato N, Oizumi T, Kinbara M, et al. Promotion of arthritis and allergy in mice by aminoglycoglycerophospholipid, a membrane antigen specific to Mycoplasma fermentans. FEMS Immunol Med Microbiol 2010;59:33-41.
106. Newkirk MM, Zbar A, Baron M, et al. Distinct bacterial colonization patterns of Escherichia coli subtypes associate with rheumatoid factor status in early inflammatory arthritis. Rheumatology (Oxford) 2010;49:1311-16.
107. Ebringer A, Ptaszynska T, Corbett M, et al. Antibodies to proteus in rheumatoid arthritis. Lancet 1985;2:305-7.
108. Ebringer A, Rashid T, Wilson C. Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmun Rev 2010;9:216-23.
109. Hunter W. Oral sepsis as a cause of disease. Br Med J 1900;2:215-6.
110. de Aquino SG, Abdollahi-Roodsaz S, Koenders MI, et al. Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response. J Immunol 2014;192:4103-11.
111. Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012;64:3083-94.
112. Wolff B, Berger T, Frese C, et al. Oral status in patients with early rheumatoid arthritis: a prospective, case-control study. Rheumatology (Oxford) 2014;53:526-31.
113. Al-Katma MK, Bissada NF, Bordeaux JM, et al. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 2007;13:134-7.
114. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 2008;79:979-86.
115. Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014;66:1090-100.
116. Okada M, Kobayashi T, Ito S, et al. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. J Periodontol 2013;84:e74-84.
117. Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009;80:535-40.
118. Hitchon CA, Chandad F, Ferucci ED, et al . Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010;37:1105-12.
119. Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009;36:1004-10.
120. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006;24:656-63.
121. Marchesan JT, Gerow EA, Schaff R, et al. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther 2013;15:R186.
122. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010;233:34-54.
123. Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014;26:101-7.
124. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010;5:e8578.
125. Segal LN, Alekseyenko AV, Clemente JC, et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 2013;1:19.
126. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-92.
127. Demoruelle MK, Weisman MH, Simonian PL, et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012;64:1756-61.
128. Fung I, Garrett JP, Shahane A, et al. Do bugs control our fate? The influence of the microbiome on autoimmunity. Curr Allergy Asthma Rep 2012;12:511-19.
129. Yeoh N, Burton JP, Suppiah P, et al. The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep 2013;15:314.
130. Taneja V. Arthritis susceptibility and the gut microbiome. FEBS Lett 2014. pii: S0014-5793(14)00421-9. Published Online First. doi:10.1016/j.febslet.2014.05.034
131. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008;118:205-16. http://www.ncbi.nlm.nih.gov/pubmed/?term=Stimulation+of+TLR2+and+TLR4+differentially+skews+the+balance+of+T+cells+in+a+mouse+model+of+arthritis
132. Wu HJ, Ivanov II, Darce J, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010;32:815-27.
133. Gomez A, Luckey D, Yeoman CJ, et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS ONE 2012;7:e36095.
134. Dorożyńska I, Majewska-Szczepanik M, Marcińska K, et al. Partial depletion of natural gut fl ora by antibiotic aggravates collagen induced arthritis (CIA) in mice. Pharmacol Rep 2014;66:250-5.
135. Vaahtovuo J, Munukka E, Korkeamäki M, et al. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008;35:1500-5.
136. Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013;2: e01202.
137. Zhou L, Li X, Ahmed A, et al. Gut microbe analysis between hyperthyroid and healthy individuals. Curr Microbiol 2014;69:675-80.
138. Penhale WJ, Young PR. The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin Exp Immunol 1988;72:288-92.
139. Szymula A, Rosenthal J, Szczerba BM, et al. T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 2014;152:1-9.
140. Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus 2014;23:518-26.
141. Costello ME, Elewaut D, Kenna TJ, et al. Microbes, the gut and ankylosing spondylitis. Arthritis Res Ther 2013;15:214.
142. Schaeverbeke T, Truchetet ME, Richez C. Gut metagenome and spondyloarthritis. Joint Bone Spine 2013;80:349-52.
143. Wallis D, Asaduzzaman A, Weisman M, et al. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study. Arthritis Res Ther 2013;15:R166.
144. Hacquard-Bouder C, Ittah M, Breban M. Animal models of HLA-B27-associated diseases: new outcomes. Joint Bone Spine 2006;73:132-8.
145. Stebbings S, Munro K, Simon MA, et al . Comparison of the faecal microfl ora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 2002;41:1395-401.
146. Stebbings SM, Taylor C, Tannock GW, et al. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. J Rheumatol 2009;36:797-800.
147. Lin P, Bach M, Asquith M, et al. HLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic Rats. PLoS ONE 2014;9:e105684.
148. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014;38:1-12.
149. Bhargava P, Mowry EM. Gut microbiome and multiple sclerosis. Curr Neurol Neurosci Rep 2014;14:492.
150. Berer K, Krishnamoorthy G. Microbial view of central nervous system autoimmunity. FEBS Lett 2014;588:4207-13.
151. Lee YK, Menezes JS, Umesaki Y, et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011;108(Suppl):4615-22.
152. Yokote H, Miyake S, Croxford JL, et al . NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 2008;173:1714-23.
153. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009;183:6041-50.
154. Ochoa-Repáraz J, Mielcarz DW, Haque-Begum S, et al. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 2010;1:103-8.
155. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011;479:538-41.
156. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol 2010;185:4101-8.
157. Ochoa-Reparaz J, Mielcarz DW, Wang Y. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 2010;3:487-95.
158. Mao Y-K, Kasper DL, Wang B, et al. Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun 2013;4:1465.
159. Wang Y, Telesford KM, Ochoa-Repáraz J, et al. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun 2014;5:4432.